2,403 results match your criteria: "Center for Vaccine Development.[Affiliation]"

Importance: Acute respiratory tract infections are the leading cause of emergency department visits and hospitalizations in US children, with highest risks in the first 2 months after birth. Out-of-home childcare settings increase the spread of respiratory tract infections. The study team hypothesized that access to state-paid family leave could reduce acute care encounters (hospital admissions or emergency department visits) for respiratory tract infections in young infants by reducing out-of-home childcare transmissions.

View Article and Find Full Text PDF

Prevalence of group B Streptococcus colonisation in mother-newborn dyads in low-income and middle-income south Asian and African countries: a prospective, observational study.

Lancet Microbe

October 2024

South Africa Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa; African Leadership in Vaccinology Expertise, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa; Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa. Electronic address:

Article Synopsis
  • The study investigates the prevalence of rectovaginal group B Streptococcus (GBS) colonization in pregnant women during labor and its transmission to newborns in selected low-income and middle-income African and South Asian countries.
  • Conducted across 11 maternity and obstetric facilities, the research involved collecting samples from 6,514 HIV-negative pregnant women at least 37 weeks gestation to analyze GBS culture and serotyping.
  • The findings revealed a 24.1% rate of maternal GBS colonization, with the highest prevalence in Mali (41.1%) and the lowest in Ethiopia (11.6%), highlighting significant regional variations in GBS rates among pregnant women.
View Article and Find Full Text PDF

Mali national policy recommends that women take iron and folic acid supplements (IFA) from the time of the first antenatal care (ANC) visit, throughout pregnancy and during the first 3 months after delivery. In 2020, the World Health Organization (WHO) updated their ANC guidelines to recommend the United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP) formulation of multiple micronutrient supplements (MMS) in the context of rigorous research, including implementation research. In Bamako, Mali, a codesign process was used to tailor antenatal care MMS packaging and counselling materials aimed at optimizing delivery and uptake of and adherence to MMS.

View Article and Find Full Text PDF

Unlabelled: parasites, the causative organism of malaria, caused over 600,000 deaths in 2022. In Mali, causes the majority of malaria cases and deaths and is transmitted seasonally. Anti-malarial immunity develops slowly over repeated exposures to and some aspects of this immunity (e.

View Article and Find Full Text PDF

How do adjuvants enhance immune responses?

Elife

August 2024

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, United States.

By altering which peptide antigens are presented to CD4 T cells, adjuvants affect the specificity of the immune response.

View Article and Find Full Text PDF

Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions.

Physiol Rev

April 2025

Center for Vaccine Development, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.

The 3',5'-cyclic adenosine monophosphate (cAMP) mediates the effects of sympathetic stimulation on the rate and strength of cardiac contraction. Beyond this pivotal role, in cardiac myocytes cAMP also orchestrates a diverse array of reactions to various stimuli. To ensure specificity of response, the cAMP signaling pathway is intricately organized into multiple, spatially confined, subcellular domains, each governing a distinct cellular function.

View Article and Find Full Text PDF

In resource-limited settings where vital registration and medical death certificates are unavailable or incomplete, verbal autopsy (VA) is often used to attribute causes of death (CoD) and prioritize resource allocation and interventions. We aimed to determine the CoD concordance between InterVA and CHAMPS's method. The causes of death (CoDs) of children <5 were determined by two methods using data from seven low- and middle-income countries (LMICs) enrolled in the Child Health and Mortality Prevention Surveillance (CHAMPS) network.

View Article and Find Full Text PDF
Article Synopsis
  • Enteric viruses are the main cause of diarrhea in children under 5, with rotavirus being a well-researched culprit in Mozambique, though other viruses lack data post-vaccine.
  • The study investigated the prevalence of norovirus GI and GII, adenovirus 40/41, astrovirus, and sapovirus in children with varying severity of diarrhea before and after the introduction of the rotavirus vaccine.
  • Results showed that all viruses, except norovirus GI, were detected more frequently after the vaccine's introduction, highlighting the importance of ongoing monitoring for these viruses to improve disease prevention strategies.
View Article and Find Full Text PDF
Article Synopsis
  • Developing broad-spectrum coronavirus vaccines is crucial for future pandemic preparedness against respiratory viruses.* -
  • A trivalent subunit vaccine was created using receptor-binding domains from three coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2 XBB.1.5, combined with adjuvants Alum and CpG55.2.* -
  • Vaccinated mice showed cross-neutralizing antibodies for all three Betacoronaviruses and some bat-exclusive viruses, suggesting good epitope preservation and potential for broader immune response.*
View Article and Find Full Text PDF
Article Synopsis
  • The text discusses a diverse species that infects both humans and animals, specifically focusing on non-typhoidal serovars (NTS) that cause foodborne illnesses and can lead to economic losses in livestock.
  • It highlights recent advancements in genetic engineering that have facilitated the development of vaccines for both humans and animals.
  • The review covers various types of vaccines, including recombinant live-attenuated vaccines, parenteral vaccines, and live-vector vaccines, with applications for both human and animal health.
View Article and Find Full Text PDF

Invasive non-typhoidal Salmonella (iNTS) disease is an under-recognized high-burden disease causing major health and socioeconomic issues in sub-Saharan Africa (sSA), predominantly among immune-naïve infants and young children, including those with recognized comorbidities such as HIV infection. iNTS disease is primarily caused by Salmonella enterica serovar Typhimurium sequence type (ST) 313 and 'African-restricted clades' of Salmonella Enteritidis ST11 that have emerged across the African continent as a series of epidemics associated with acquisition of new antimicrobial resistance. Due to genotypes with a high prevalence of antimicrobial resistance and scarcity of therapeutic options, these NTS serovars are designated by the World Health Organization as a priority pathogen for research and development of interventions, including vaccines, to address and reduce NTS associated bacteremia and meningitis in sSA.

View Article and Find Full Text PDF

A new landscape for malaria vaccine development.

PLoS Pathog

June 2024

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.

View Article and Find Full Text PDF

Typhoid fever is responsible for a substantial health burden in low- and middle-income countries (LMICs). New means of prevention became available with the prequalification of typhoid conjugate vaccines (TCV) by the World Health Organization (WHO) in 2018. Policymakers require evidence to inform decisions about TCV.

View Article and Find Full Text PDF

Introduction: Non-typhoidal (NTS) generally causes self-limiting gastroenteritis. However, older adults (≥65 years) can experience more severe outcomes from NTS infection. We have previously shown that a live attenuated .

View Article and Find Full Text PDF

Does behavior mediate the effect of weather on SARS-CoV-2 transmission? evidence from cell-phone data.

PLoS One

June 2024

Department of Environmental and Occupational Health, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.

There is growing evidence that weather alters SARS-CoV-2 transmission, but it remains unclear what drives the phenomenon. One prevailing hypothesis is that people spend more time indoors in cooler weather, leading to increased spread of SARS-CoV-2 related to time spent in confined spaces and close contact with others. However, the evidence in support of that hypothesis is limited and, at times, conflicting.

View Article and Find Full Text PDF

CountASAP: A Lightweight, Easy to Use Python Package for Processing ASAPseq Data.

bioRxiv

May 2024

Computational Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

Declining sequencing costs coupled with the increasing availability of easy-to-use kits for the isolation of DNA and RNA transcripts from single cells have driven a rapid proliferation of studies centered around genomic and transcriptomic data. Simultaneously, a wealth of new techniques have been developed that utilize single cell technologies to interrogate a broad range of cell-biological processes. One recently developed technique, transposase-accessible chromatin with sequencing (ATAC) with select antigen profiling by sequencing (ASAPseq), provides a combination of chromatin accessibility assessments with measurements of cell-surface marker expression levels.

View Article and Find Full Text PDF

Resistance to clinical malaria takes years to develop even in hyperendemic regions and sterilizing immunity has rarely been observed. To evaluate the maturation of the host response against controlled repeat exposures to P. falciparum (Pf) NF54 strain-infected mosquitoes, we systematically monitored malaria-naïve participants through an initial exposure to uninfected mosquitoes and 4 subsequent homologous exposures to Pf-infected mosquitoes over 21 months (n = 8 males) (ClinicalTrials.

View Article and Find Full Text PDF

A hallmark of cerebral malaria is sequestration of Plasmodium falciparum-infected erythrocytes (IEs) in the brain microcirculation. Antibodies contribute to malaria immunity, but it remains unclear whether functional antibodies targeting parasite-expressed ligand can block cytoadhesion in the brain. Here, we screened the plasma of older children and young adults in Malawi to characterize the antibody response against the P.

View Article and Find Full Text PDF

, , and are three of the most widespread vectors of malaria parasites, with geographical ranges stretching across wide swaths of Africa. Understanding the population structure of these closely related species, including the extent to which populations are connected by gene flow, is essential for understanding how vector control implemented in one location might indirectly affect vector populations in other locations. Here, we assessed the population structure of each species based on a combined data set of publicly available and newly processed whole-genome sequences.

View Article and Find Full Text PDF

Flagellum-mediated motility is essential to Pseudomonas aeruginosa (P. aeruginosa) virulence. Antibody against flagellin reduces motility and inhibits the spread of the bacteria from the infection site.

View Article and Find Full Text PDF

Generation and Characterization of In Vitro Transcribed mRNA.

Methods Mol Biol

May 2024

Baylor College of Medicine, Department of Pediatrics, Division of Pediatric Tropical Medicine, Houston, TX, USA.

Article Synopsis
  • The text outlines the process for creating mRNA from DNA templates, detailing the steps for transcription, capping, and labeling of the mRNA.
  • It discusses various characterization techniques such as UV and fluorescence spectrophotometry, gel electrophoresis, and the use of the Bioanalyzer for higher resolution analysis of the synthesized RNA.
  • Lastly, it provides protocols for testing the synthesized mRNA in primary cell cultures, including methods for confirming translation through intracellular staining and western blotting.
View Article and Find Full Text PDF

A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein.

EBioMedicine

June 2024

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; University of Maryland School of Medicine, Department of Microbiology and Immunology, Baltimore, MD 21201, USA; University of Maryland School of Medicine, Center for Vaccine Development and Global Health (CVD), Baltimore, MD 21201, USA. Electronic address:

Background: The development of a universal influenza virus vaccine, to protect against both seasonal and pandemic influenza A viruses, is a long-standing public health goal. The conserved stalk domain of haemagglutinin (HA) is a promising vaccine target. However, the stalk is immunosubdominant.

View Article and Find Full Text PDF

Importance: SARS-CoV-2 viral load (VL) in the nasopharynx is difficult to quantify and standardize across settings, but it may inform transmission potential and disease severity.

Objective: To characterize VL at COVID-19 diagnosis among previously uninfected and unvaccinated individuals by evaluating the association of demographic and clinical characteristics, viral variant, and trial with VL, as well as the ability of VL to predict severe disease.

Design, Setting, And Participants: This secondary cross-protocol analysis used individual-level data from placebo recipients from 4 harmonized, phase 3 COVID-19 vaccine efficacy trials sponsored by Moderna, AstraZeneca, Janssen, and Novavax.

View Article and Find Full Text PDF